CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2022	$ 103,900	$ 4	$ 502,613	$ (399,118)	$ 401
Beginning balance, Shares at Dec. 31, 2022		42,922,980
Issuance of common stock upon exercise of stock options	23		23
Issuance of common stock upon exercise of stock options, shares		17,109
Issuance of common stock related to ESPP purchase	461		461
Issuance of common stock related to ESPP purchase, shares		562,493
Stock-based compensation expense related to employee stock awards	6,478		6,478
Stock-based compensation expense related to employee stock purchases	382		382
Vesting of early exercised common stock options	41		41
Other comprehensive income (loss)	96				96
Net income (loss)	(41,746)			(41,746)
Ending balance at Jun. 30, 2023	69,635	$ 4	509,998	(440,864)	497
Ending balance, Shares at Jun. 30, 2023		43,502,582
Beginning balance at Mar. 31, 2023	84,750	$ 4	506,320	(422,073)	499
Beginning balance, Shares at Mar. 31, 2023		42,940,089
Issuance of common stock related to ESPP purchase	461		461
Issuance of common stock related to ESPP purchase, shares		562,493
Stock-based compensation expense related to employee stock awards	2,975		2,975
Stock-based compensation expense related to employee stock purchases	222		222
Vesting of early exercised common stock options	20		20
Other comprehensive income (loss)	(2)				(2)
Net income (loss)	(18,791)			(18,791)
Ending balance at Jun. 30, 2023	69,635	$ 4	509,998	(440,864)	497
Ending balance, Shares at Jun. 30, 2023		43,502,582
Beginning balance at Dec. 31, 2023	92,080	$ 7	578,325	(486,797)	545
Beginning balance, Shares at Dec. 31, 2023		75,096,906
Issuance of common stock related to ESPP purchase	297		297
Issuance of common stock related to ESPP purchase, shares		560,971
Issuance of common stock from RSU vesting, shares		2,490
Issuance of common stock upon exercise of pre-funded warrants	1	$ 1
Issuance of common stock upon exercise of pre-funded warrants, shares		4,125,531
Stock-based compensation expense related to employee stock awards	4,417		4,417
Stock-based compensation expense related to employee stock purchases	287		287
Other comprehensive income (loss)	(51)				(51)
Net income (loss)	(29,802)			(29,802)
Ending balance at Jun. 30, 2024	67,229	$ 8	583,326	(516,599)	494
Ending balance, Shares at Jun. 30, 2024		79,785,898
Beginning balance at Mar. 31, 2024	59,796	$ 7	580,973	(521,660)	476
Beginning balance, Shares at Mar. 31, 2024		75,668,521
Issuance of common stock related to ESPP purchase	297		297
Issuance of common stock related to ESPP purchase, shares		560,971
Issuance of common stock upon exercise of pre-funded warrants	1	$ 1
Issuance of common stock upon exercise of pre-funded warrants, shares		3,556,406
Stock-based compensation expense related to employee stock awards	1,918		1,918
Stock-based compensation expense related to employee stock purchases	138		138
Other comprehensive income (loss)	18				18
Net income (loss)	5,061			5,061
Ending balance at Jun. 30, 2024	$ 67,229	$ 8	$ 583,326	$ (516,599)	$ 494
Ending balance, Shares at Jun. 30, 2024		79,785,898